Literature DB >> 3856223

Expression of human adenosine deaminase using a transmissable murine retrovirus vector system.

R L Friedman.   

Abstract

Human adenosine deaminase (ADA; adenosine aminohydrolase, EC 3.5.4.4) was expressed at high levels in cultured mouse cells using a transmissable murine retrovirus vector system. A cDNA clone encoding ADA has been inserted into a plasmid vector containing retroviral transcription and packaging signals as well as a selectable gene for G418 resistance. The constructions were transfected into psi 2 cells, which package the recombinant retroviral genomes into replication-defective virus particles. Isoenzyme analysis for ADA in G418-selected psi 2 cells showed at least 20-fold more human ADA activity than endogenous mouse ADA activity. A mouse T-cell lymphoma line, BL/VL3, was cocultured with transformed psi 2 cells producing human ADA, and some of the cocultured cells were selected for resistance to G418. Both G418-selected and unselected cocultured cells expressed human ADA activity at 25%-50% the level of the endogenous enzyme. Thus, efficient retroviral transduction of ADA expression was obtained.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3856223      PMCID: PMC397114          DOI: 10.1073/pnas.82.3.703

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Adenosine deaminase activity in thymus and other human tissues.

Authors:  A Adams; R A Harkness
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Human adenosine deaminase. Distribution and properties.

Authors:  M B Van der Weyden; W N Kelley
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

4.  Construction and characterization of new cloning vehicles. III. Derivatives of plasmid pBR322 carrying unique Eco RI sites for selection of Eco RI generated recombinant DNA molecules.

Authors:  F Bolivar
Journal:  Gene       Date:  1978-10       Impact factor: 3.688

5.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

6.  Adenosine deaminase deficiency: frequency and comparative pathology in autosomally recessive severe combined immunodeficiency.

Authors:  R Hirschhorn; G F Vawter; J A Kirkpatrick; F S Rosen
Journal:  Clin Immunol Immunopathol       Date:  1979-09

7.  Adenosine deaminase, terminal deoxynucleotidyl transferase (TdT), and cell surface markers in childhood acute leukemia.

Authors:  M S Coleman; M F Greenwood; J J Hutton; P Holland; B Lampkin; C Krill; J E Kastelic
Journal:  Blood       Date:  1978-12       Impact factor: 22.113

8.  Regulation of simian virus 40 transcription: sensitive analysis of the RNA species present early in infections by virus or viral DNA.

Authors:  B A Parker; G R Stark
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

9.  Hereditary sever combined immunodeficiency and adenosine deaminase deficiency.

Authors:  C Ackeret; H J Llüss; W H Hitzig
Journal:  Pediatr Res       Date:  1976-01       Impact factor: 3.756

10.  High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range.

Authors:  R D Cone; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

View more
  14 in total

1.  Expression of human class II major histocompatibility complex antigens using retrovirus vectors.

Authors:  A J Korman; J D Frantz; J L Strominger; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

2.  In vitro development of B lymphocytes from long-term cultured precursor cells.

Authors:  K A Denis; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

3.  Regulated expression of a complete human beta-globin gene encoded by a transmissible retrovirus vector.

Authors:  R D Cone; A Weber-Benarous; D Baorto; R C Mulligan
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

Review 4.  Retroviral-mediated gene transfer. Applications in neurobiology.

Authors:  M M Lo; M K Conrad; C Mamalaki; M J Kadan
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

5.  High-efficiency identification of genes by functional analysis from a retroviral cDNA expression library.

Authors:  B Y Wong; H Chen; S W Chung; P M Wong
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

6.  High mutation rate of a spleen necrosis virus-based retrovirus vector.

Authors:  J P Dougherty; H M Temin
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

7.  Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells.

Authors:  J M Wilson; O Danos; M Grossman; D H Raulet; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

8.  Coordinate regulation of mRNAs encoding adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyltransferase by phorbol esters in human thymocytes.

Authors:  H Martinez-Valdez; A Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

9.  Selection and amplification of heterologous genes encoding adenosine deaminase in mammalian cells.

Authors:  R J Kaufman; P Murtha; D E Ingolia; C Y Yeung; R E Kellems
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

10.  Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer.

Authors:  P W Kantoff; D B Kohn; H Mitsuya; D Armentano; M Sieberg; J A Zwiebel; M A Eglitis; J R McLachlin; D A Wiginton; J J Hutton
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.